China NMPA Drug Inspection - Sanmenxia Sanov Pharmaceutical Co., Ltd. - Thrombosis-reducing enteric-coated capsules [Thrombolysis Capsules (Enteric-coated)]
China NMPA drug inspection for Sanmenxia Sanov Pharmaceutical Co., Ltd. published September 30, 2018. Drug: Thrombosis-reducing enteric-coated capsules [Thrombolysis Capsules (Enteric-coated)]. The National Medical Products Administration (NMPA) of China announced on September 30, 2018, the findings from inspecti
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Sanmenxia Sanov Pharmaceutical Co., Ltd. published September 30, 2018. Drug: Thrombosis-reducing enteric-coated capsules [Thrombolysis Capsules (Enteric-coated)]. The National Medical Products Administration (NMPA) of China announced on September 30, 2018, the findings from inspecti
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox